CVIA Journal

9.7K posts

CVIA Journal banner
CVIA Journal

CVIA Journal

@CVIA_Journal

Platinum open-access journal in cardiovascular medicine. Impact Factor 1.4 CiteScore 1.2 Publishing innovative research with rapid peer review & no author fees

Katılım Ekim 2015
4.2K Takip Edilen4.1K Takipçiler
CVIA Journal retweetledi
Heart_SCCT
Heart_SCCT@Heart_SCCT·
2025 Masterclass: Congenital Advanced CT insights into congenital coronary abnormalities & complex CHD, with practical guidance for anatomical assessment, long-term care & procedural planning. ow.ly/Tm5E50YBSeW
Heart_SCCT tweet media
English
0
1
4
326
CVIA Journal retweetledi
TCTMD
TCTMD@TCTMD·
Noninvasive FFR measurements have similar clinical outcomes as conventional wire-based physiology assessments 1 year after revascularization, according to two different trial results presented at the recent #ACC2026—ALL-RISE and FAST III. tctmd.com/news/noninvasi…
TCTMD tweet media
English
0
7
15
2.1K
CVIA Journal retweetledi
American College of Cardiology
The 🆕 #CVD Risk Estimator Plus app helps estimate 10- & 30-year risks for total CVD, #ASCVD, & HF, using the combined strength of the new AHA PREVENT™ equations, as well as the previous Pooled Cohort Equations, for reference & comparison. Download now: bit.ly/4898nCg
American College of Cardiology tweet media
English
1
13
24
4.7K
CVIA Journal retweetledi
American College of Cardiology
📺 Panel Discussion from #ACC26: Dive into the 🆕 Dyslipidemia Guideline and VESALIUS-CV Late-Breaking Clinical Trial with Drs. Fred Kusumoto, Scott Wright, and @DrEugeneYang. Watch now on ACC Anywhere TV! ➡️ bit.ly/4c2CRXU
American College of Cardiology tweet media
English
0
6
14
2.2K
CVIA Journal retweetledi
TCTMD
TCTMD@TCTMD·
The addition of the PCSK9 inhibitor evolocumab to statin therapy is very effective for reducing major CV events in high-risk patients without ASCVD when compared with statins alone, based on analysis from the VESALIUS-CV trial. tctmd.com/audio/evolutio… @marstonMD #ACC2026
TCTMD tweet media
English
0
7
10
954
CVIA Journal retweetledi
Radcliffe Cardiology
Radcliffe Cardiology@radcliffeCARDIO·
✨ Whats new from ACC? ➡️ Interpreting new ATTR-CM data: ow.ly/WrSN50YCqLH Explore the clinical utility of near-complete TTR stabilisation and new data from the ATTRibute-CM trial. This programme is supported by an unrestricted educational grant from Bayer.
Radcliffe Cardiology tweet media
English
0
1
4
256
CVIA Journal retweetledi
Heart_SCCT
Heart_SCCT@Heart_SCCT·
Free sponsored webinar | Thursday, Apr 23 at 7pm ET | Optimizing contrast in cardiovascular CT: Safety, strategy and techniques| Sponsored by BD Register: ow.ly/vfyj50YyKWU
Heart_SCCT tweet media
English
0
2
2
418
CVIA Journal retweetledi
Radcliffe Cardiology
Radcliffe Cardiology@radcliffeCARDIO·
🚨#ACC26 Late-Breaker Discussion with Dr Van Spall: Dig-RHD Dr @hvanspall & Dr Ganesan Karthikeyan unpack Dig-RHD - the first RCT testing digoxin in rheumatic heart disease + HF. Does it cut symptoms, admissions, mortality in high-burden low- and middle-income settings? 🎥Watch the full late-breaker discussion here: radc.life/Dbd0NtxF #CardioX #LateBreaking #DigRHD #RheumaticHeartDisease #HeartFailure #Digoxin #Cardiology #ClinicalTrials @ACCintouch
English
0
4
11
7K